## Core Concept
Thrombocytopenia, a condition characterized by abnormally low levels of platelets in the blood, can be an adverse reaction to certain vaccines. This condition arises due to immune-mediated mechanisms or direct effects on platelet production or destruction. The key here is to identify which vaccine is associated with this specific adverse reaction.

## Why the Correct Answer is Right
The correct answer, **D. Dengue vaccine**, is linked to thrombocytopenia as an adverse reaction. The Dengue vaccine, particularly the Dengvaxia (CYD-TDV), has been associated with increased risks of severe disease and adverse events, including thrombocytopenia, especially in individuals without previous dengue infection. This association underscores the importance of careful consideration of vaccine administration based on individual risk factors and immune status.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because there is no widely recognized or specific association of thrombocytopenia directly with this vaccine as a notable adverse reaction in the literature.
- **Option B:** Similarly, this option does not have a well-documented association with thrombocytopenia as a significant adverse reaction.
- **Option C:** This option also lacks a prominent association with thrombocytopenia compared to the correct answer.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that vaccines, like any medical intervention, can have adverse effects, and the risk-benefit ratio must be carefully considered. Specifically, for the Dengue vaccine, monitoring for signs of thrombocytopenia or other adverse effects is crucial, especially in areas where dengue is endemic and the risk of exposure is high.

## Correct Answer: D. Dengue vaccine.